Top Markets
#1 Pleasing Gold Pleasing Gold +1,546.27%
#2 PulseChain PulseChain +55.72%
#3 Ontology Gas Ontology Gas +36.94%
#4 DogBull DogBull +36.89%
#5 BOOK OF MEME BOOK OF MEME +30.55%
#6 Neiro Neiro +21.85%
#7 Collect on Fanable Collect on Fanable +21.43%
#8 Nockchain Nockchain +19.56%
#9 Pump.fun Pump.fun +19.14%
#10 Unit Pump Unit Pump +19.14%
Coin of the day
Pleasing Gold Pleasing Gold
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Rang in Aktien #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Aktienkurs
$0.12164306
Zuletzt synchronisiert: 2024-11-11
Marktkapitalisierung
$38.53M
Veränderung (1 Tag)
-4.14%
Veränderung (1 Jahr)
0.00%
Land
AU
Handel PharmAust Limited (PAA)

Kategorie

Healthcare
Anzahl der ausstehenden Aktien von PharmAust Limited (PAA)
Anzahl der ausstehenden Aktien zum June 2024: 445.02M
Laut den neuesten Finanzberichten und dem Aktienkurs von PharmAust Limited beträgt die aktuelle Anzahl der ausstehenden Aktien 445.02M. Am Ende von June 2023 hatte das Unternehmen 321.01M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von PharmAust Limited (PAA) von 2001 bis 2026
Ausstehende Aktien am Ende jedes Jahres
Jahr Ausstehende Aktien ändert
2026 (TTM) 445.02M 20.01%
2024 370.81M 15.51%
2023 321.01M 1.30%
2022 316.88M 0.36%
2021 315.74M 6.66%
2020 296.03M 34.97%
2019 219.33M 49.63%
2018 146.58M 17.67%
2017 124.57M 34.66%
2016 92.50M 21.95%
2015 75.85M 13.88%
2014 66.61M 114.63%
2013 31.04M 18.66%
2012 26.15M 61.59%
2011 16.19M 11.04%
2010 14.58M 5.14%
2009 13.86M 15.26%
2008 12.03M 92.28%
2007 6.26M 37.82%
2006 4.54M 35.07%
2005 3.36M 77.75%
2004 1.89M 44.03%
2003 1.31M 21.85%
2002 1.08M 32.47%
2001 813.21K 0.00%
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
Unternehmen Ausstehende Aktien Unterschied Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -42.95%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -86.03%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M 8.66%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -11.02%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH